API
BIO icon

Advisor Partners II’s Bio-Rad Laboratories Class A BIO Stock Holding History

Advisor Partners II’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$479K Buy
1,336
+268
+25% +$103K 0.02% 740
2023
Q2 		$405K Sell
1,068
-602
-36% -$245K 0.02% 671
2023
Q1 		$800K Buy
1,670
+295
+21% +$138K 0.04% 407
2022
Q4 		$578K Buy
1,375
+407
+42% +$164K 0.04% 481
2022
Q3 		$404K Buy
+968
New +$483K 0.03% 517

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Advisor Partners II's BIO Position: Q3 2023 in Review

Advisor Partners II increased its Bio-Rad Laboratories Class A (BIO) stake by 25% in Q3 2023, buying an estimated $103K and bringing the position to 1,336 shares worth $479K. The position accounts for 0.02% of the portfolio, ranked #740.

Advisor Partners II first reported a position in BIO in Q3 2022 and has held it in 5 quarters since. The position peaked at $800K in Q1 2023. 467 funds tracked by Wall St. Rank hold BIO as of Q3 2023.

  • Advisor Partners II held 1,336 shares of Bio-Rad Laboratories Class A worth $479K as of Q3 2023.
  • Advisor Partners II bought 268 Bio-Rad Laboratories Class A shares in Q3 2023, an estimated $103K.
  • Bio-Rad Laboratories Class A made up 0.02% of Advisor Partners II's portfolio in Q3 2023, its #740 holding.
  • Advisor Partners II first reported a position in Bio-Rad Laboratories Class A in Q3 2022 and has held it in 5 quarters since.
  • Advisor Partners II's Bio-Rad Laboratories Class A position peaked at $800K in Q1 2023.
  • 467 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2023.

Based on Advisor Partners II's 13F filing for Q3 2023, filed 26 Oct 2023.